Stay updated on Nivolumab Ipilimumab RT for Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab RT for Sarcoma Clinical Trial page.
Latest updates to the Nivolumab Ipilimumab RT for Sarcoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe Publications section now notes that PubMed publications are automatically filled and may not be about the study, and a new revision tag v3.3.2 was added (replacing v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check28 days agoChange DetectedRemoved the government funding and operating status notice that appeared on the page.SummaryDifference0.3%
- Check42 days agoChange DetectedThe Study Details page shows a refreshed layout and updated labels, with core study information and eligibility criteria remaining unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check71 days agoChange DetectedThe page now shows newer operating status information, updated timing and version details (v3.2.0) with new dates, while old dates and the previous revision (v3.1.0) are removed.SummaryDifference3%
- Check78 days agoChange DetectedMajor update toward immunology and biomedical content (new topics like antigens, receptors, immune checkpoints) with removal of unrelated physics topics; page revision updated to v3.1.0.SummaryDifference1%
- Check93 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.1%
Stay in the know with updates to Nivolumab Ipilimumab RT for Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab RT for Sarcoma Clinical Trial page.